Advertisement
ABT vs ALC
Which Stock Would AI Choose? Abbott Laboratories (ABT) vs. Alcon Inc. (ALC) Stock Comparison
Key Takeaways
- ABT and ALC both operate in the healthcare equipment and supplies sector, with ABT offering broader diversification across diagnostics, nutrition, and devices while ALC focuses exclusively on eye care.
- Recent market activity shows both companies delivered second-quarter results that exceeded expectations, with ABT reporting double-digit reported sales growth and ALC achieving solid constant-currency gains driven by new product launches.
- ABT maintains a longer track record of consecutive dividend payments and a larger market capitalization, providing relative stability compared to ALC's more concentrated business model.
- Sector exposure differs notably: ABT benefits from multiple therapeutic areas including diabetes management and electrophysiology, whereas ALC capitalizes on recurring revenue from surgical consumables and vision care products.
- Market sentiment for both has been influenced by product innovation and regulatory resolutions, with ABT navigating a recent settlement and ALC advancing its UNITY platform rollout.
- Relative performance in recent weeks reflects broader healthcare trends, where established players like ABT exhibit lower volatility than pure-play specialists such as ALC.
Introduction
Investors and traders seeking to compare healthcare equipment stocks often evaluate ABT and ALC due to their distinct yet overlapping positions in medical devices and supplies. ABT, known as Abbott Laboratories, spans diagnostics, nutrition, and cardiovascular technologies, while ALC, or Alcon Inc., specializes in ophthalmic surgery and vision care. This comparison appeals to those analyzing relative performance, sector exposure, and growth drivers within healthcare amid evolving market conditions. Portfolio managers and active traders may find the analysis useful for assessing diversification opportunities or momentum shifts between a diversified multinational and a focused eye-care leader.
ABT Overview and Recent Performance
Abbott Laboratories operates across four primary segments: established pharmaceuticals, diagnostic products, nutritional products, and medical devices. The company has maintained consistent dividend growth, declaring its 411th consecutive quarterly payout in recent market activity. In the most recent quarter, ABT posted reported sales growth of 13 percent alongside a comparable increase of 4.8 percent, supported by strength in medical devices including continuous glucose monitoring and electrophysiology. Recent developments include FDA authorizations for new systems and resolution of legacy matters through a settlement agreement. Stock behavior in recent weeks has reflected these catalysts alongside broader market movements, with the share price trading near $102 amid a market capitalization exceeding $177 billion. Sentiment has been shaped by guidance revisions and innovation milestones that underscore operational execution.
ALC Overview and Recent Performance
Alcon Inc. concentrates on eye care, with surgical and vision care segments generating recurring revenue from equipment, intraocular lenses, and contact lenses. The company reported second-quarter sales of $2.8 billion, reflecting an 8 percent reported increase and 7 percent constant-currency growth, fueled by commercial execution and new platform introductions. Recent activity highlights advancement of the UNITY surgical ecosystem and collaborations to enhance premium lens offerings. In recent market activity, ALC shares have traded around $65, corresponding to a market capitalization near $31 billion. Performance has been influenced by margin expansion initiatives and product pipeline progress, contributing to updated profitability guidance. Sentiment remains tied to execution on launches and international volume trends within the ophthalmology space.
Trending AI Robots
Tickeron maintains a curated selection of AI trading bots designed to navigate thousands of tickers across varied market conditions. Hundreds of bots are available overall, each employing distinct strategies, timeframes, and performance profiles, yet only those demonstrating the strongest alignment with prevailing trends and risk parameters earn placement in the Trending AI Robots section. Available statistics often highlight ranges such as win rates, drawdowns, and return profiles that reflect diverse trading styles from short-term momentum to longer-horizon mean-reversion approaches. This section provides traders with data-driven options tailored to current environments. For further details, visit Trending AI Robots.
Head-to-Head Comparison
ABT and ALC contrast sharply in scale and scope. ABT benefits from multi-segment diversification that buffers against single-category volatility, while ALC derives stability from high-margin consumables in ophthalmology. Growth drivers for ABT include diabetes care and structural heart technologies; ALC emphasizes premium surgical platforms and vision products. Recent momentum favors both through earnings beats, though ABT carries additional legacy resolution factors. Risk profiles differ with ABT exposed to regulatory and litigation elements across broader operations, whereas ALC faces execution risks tied to new device adoption. Market sentiment reflects healthcare defensiveness, with ABT offering dividend consistency and ALC providing pure-play exposure to aging demographics in eye health.
Tickeron AI Verdict
Based on observable factors including trend consistency, earnings delivery, and positioning within healthcare, Tickeron’s AI models currently assign a modestly higher probabilistic preference to ABT over ALC. This assessment draws from ABT’s broader revenue base, established dividend history, and multiple recent product catalysts that support steadier momentum signals. ALC demonstrates competitive growth in its niche but exhibits comparatively narrower sector exposure. The edge remains probabilistic and subject to ongoing market dynamics rather than a definitive ranking.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and ALC is a Hold.
ABT | ALC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 68 | 88 | |
PRICE GROWTH RATING 1..100 | 58 | 71 | |
P/E GROWTH RATING 1..100 | 7 | 13 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABT's Valuation (4) in the Medical Specialties industry is in the same range as ALC (18) in the Hospital Or Nursing Management industry. This means that ABT’s stock grew similarly to ALC’s over the last 12 months.
ABT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry. This means that ABT’s stock grew similarly to ALC’s over the last 12 months.
ABT's SMR Rating (68) in the Medical Specialties industry is in the same range as ALC (88) in the Hospital Or Nursing Management industry. This means that ABT’s stock grew similarly to ALC’s over the last 12 months.
ABT's Price Growth Rating (58) in the Medical Specialties industry is in the same range as ALC (71) in the Hospital Or Nursing Management industry. This means that ABT’s stock grew similarly to ALC’s over the last 12 months.
ABT's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as ALC (13) in the Hospital Or Nursing Management industry. This means that ABT’s stock grew similarly to ALC’s over the last 12 months.
| ABT | ALC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 44% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 55% | 7 days ago 45% |
| MACD ODDS (%) | 4 days ago 59% | N/A |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 49% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 51% |
| Advances ODDS (%) | 10 days ago 57% | 3 days ago 57% |
| Declines ODDS (%) | 2 days ago 55% | 7 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 41% | 2 days ago 59% |
| Aroon ODDS (%) | 2 days ago 57% | 2 days ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 2 FA rating(s) are green while ALC’s FA Score has 2 green FA rating(s).
- ABT’s FA Score: 2 green, 3 red.
- ALC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 5 TA indicator(s) are bullish while ALC’s TA Score has 4 bullish TA indicator(s).
- ABT’s TA Score: 5 bullish, 6 bearish.
- ALC’s TA Score: 4 bullish, 5 bearish.
Price Growth
ABT (@Medical/Nursing Services) experienced а -4.50% price change this week, while ALC (@Pharmaceuticals: Other) price change was -0.98% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.00%. For the same industry, the average monthly price growth was -5.06%, and the average quarterly price growth was -2.61%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.35%. For the same industry, the average monthly price growth was -3.96%, and the average quarterly price growth was +14.04%.
Reported Earning Dates
ABT is expected to report earnings on Oct 21, 2026.
ALC is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.00% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-2.35% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
ABT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.